Evidence map›Paper›PMID 33238906›Full record

ArticleBMC nephrology2020

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).

Peiyuan Li, Chenqi Xia, Peng Liu, Zhong Peng, Hong Huang, Juan Wu, Zhangxiu He

Abstract read
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peiyuan LiDepartment of Gastroenterology, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
Chenqi XiaDepartment of Nephrology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, 421001, PR China.
Peng LiuDepartment of Nephrology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, 421001, PR China.
Zhong PengDepartment of Gastroenterology, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
Hong HuangInstitute of Clinical Medicine, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
Juan WuDepartment of Gastroenterology, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
Zhangxiu HeDepartment of Nephrology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, 421001, PR China. hezhangxiu20150724@126.com.ORCID 0000-0001-6120-9842

Funding

National Natural Science Foundation of China 81900678Natural Science Foundation of Hunan Province 2019JJ50555
6 · The paper itself

Abstract

backgroundNeutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to be associated with inflammation in end-stage renal disease (ESRD) receiving dialysis. However, the value of NLR and PLR in non-dialysis patients with ESRD remains unclear.

methodsAmong 611 non-dialysis patients with ESRD in The First Affiliated Hospital of University of South China (2012-2018), we compared NLR and PLR in patients with high-sensitivity C-reactive protein (hs-CRP) levels of ≤3 mg/L vs. > 3 mg/L. Correlation of NLR and PLR to hs-CRP, PCT, ferritin were analyzed. Receiver operating characteristics (ROC) analysis was used for estimating sensitivity and specificity of NLR and PLR.

resultsNLR was higher in the patients with high hs-CRP levels (> 3 mg/L), compared to patients with low hs-CRP levels (≤ 3 mg/L) [5.74 (3.54-9.01) vs. 3.96 (2.86-5.85), p < 0.0001]. Additionally, PLR was higher in high hs-CRP group than in low group [175.28 (116.67-252.26) vs. 140.65 (110.51-235.17), p = 0.022]. In the current study, NLR and PLR were both positively correlated with hs-CRP (rs = 0.377, p = 0.000 for NLR; rs = 0.161, p = 0.001 for PLR), PCT, leukocytes, neutrophils, platelets, and age. NLR or PLR with a cut-off value of 5.07 or 163.80 indicated sensitivity and specificity were 65.67 and 66.37% (AUC = 0.69) or 57.21 and 57.52% (AUC = 0.55), respectively.

conclusionsNLR or PLR was positively correlated with hs-CRP in non-dialysis patients with ESRD. NLR might be better for identifying inflammation than PLR in this population.

Indexed as

LymphocytesNeutrophilsPlatelet CountAdultBiomarkersC-Reactive ProteinFemaleHumansInflammationKidney Failure, ChronicLeukocyte CountMaleMiddle AgedROC CurveSensitivity and SpecificityBiomarkersC-Reactive ProteinInflammationNeutrophil-to-lymphocyte ratio (NLR)Non-dialysis patients with end-stage renal disease (ESRD)Platelet-to-lymphocyte ratio (PLR)

Identifiers

PMID33238906
PMCPMC7690201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.